Department of Thoracic & Cardiovascular Surgery, Heart Vascular & Thoracic Institute, Cleveland Clinic Foundation, OH 44195, USA.
Ross University School of Medicine, Bridgetown, BB11093, Barbados.
Future Cardiol. 2021 Sep;17(6):971-984. doi: 10.2217/fca-2020-0177. Epub 2021 Feb 10.
Left ventricular assist devices (LVADs) have changed the landscape of treatment options for patients with end stage heart failure. Due to the limited availability of donor hearts for transplantation, LVADs have become an important option for many of these patients. Much progress has been made in the device industry since then, and newer devices continue to improve patient outcomes. In this review, we will discuss some of the key transitions in LVADs over the years, the current LVADs used in practice today, implantation techniques, the impact of the new heart allocation system on LVAD use and future prospective LVADs.
左心室辅助装置（LVAD）改变了终末期心力衰竭患者的治疗选择格局。由于可供移植的供体心脏有限，LVAD 已成为许多此类患者的重要选择。从那时起，设备行业取得了很大进展，新型设备不断改善患者的治疗效果。在本次综述中，我们将讨论近年来 LVAD 的一些关键转变、目前在临床中使用的 LVAD、植入技术、新的心脏分配系统对 LVAD 使用的影响以及未来的 LVAD 前景。
